Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02495537

Ligand	Ligand name	Chain	PDB	Tanimoto
MUS	4-METHYL-2-OXO-2H-CHROMEN-7-YL 5-(ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO-NON-2-ULOPYRANOSIDONIC ACID	A	1S0J	0.73
AKT	10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT)	A	1Q0R	0.71
545	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]-(1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL-PIPERIDIN-2-YL)- ACETIC ACID BUTYL ESTER	A	1JIK	0.72
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.7
AP1	{3-[3-(3,4-DIMETHOXY-PHENYL)-1-(1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)-PROPYL]-PHENOXY}-ACETIC ACID	A,B	1BL4	0.74
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.74
NGU	U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN	A,B	1D22	0.72
AKY		A,B,C,D	2IPI	0.71
PH5	2-PHENYL-PROP5AC	A,B	2BVE	0.71
AAU	(5R,6R)-5-BENZYL-6-HYDROXY-2,4-BIS(4-HYDROXY-3-METHOXYBENZYL)-1-[3-(4-HYDROXYPHENYL)PROPANOYL]-1,2,4-TRIAZEPAN-3-ONE	B	2A4F	0.71
XN3	N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE	A,B	1K6P	0.72
REN	(S)-reticuline	A	3FWA	0.74
REN	(S)-reticuline	A	3D2D	0.74
AB8	(1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE	A,B	1XDG	0.78
AAY	8-[2-((2S)-4-HYDROXY-1-{[5-(HYDROXYMETHYL)-6-METHOXY-2-NAPHTHYL]METHYL}-6-OXOPIPERIDIN-2-YL)ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2-METHYLBUTANOATE	A,B	1XDD	0.74
XN2	N-[2-HYDROXY-1-INDANYL]-5-[(2-TERTIARYBUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4-HYDROXY-2-(1-PHENYLETHYL)-PENTANAMIDE	A,B	1K6V	0.72
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.72
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.72
HMT	(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine	0,1,2,3,9,A,B,C,F,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G6E	0.73
GUM	4-METHYL-UMBELLIFERYL-N-ACETYL-CHITOBIOSE	A	1BB7	0.73
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.74
MNG	MENOGARIL	A,B	202D	0.71
NGM	NOGALAMYCIN	A,B,C,D	258D	0.72
NGM	NOGALAMYCIN	A	282D	0.72
NGM	NOGALAMYCIN	A,B	224D	0.72
NGM	NOGALAMYCIN	A,B	245D	0.72
NGM	NOGALAMYCIN	A,B	1QCH	0.72
NGM	NOGALAMYCIN	A	1D17	0.72
NGM	NOGALAMYCIN	A,B	1D21	0.72
NGM	NOGALAMYCIN	A,B	182D	0.72
SFA	SANGLIFEHRIN A	A,B	1YND	0.7
UMG	METHYL-UMBELLIFERTL-N-ACETYL-CHITOTRIOSE	A	1BB6	0.72
NOV	NOVOBIOCIN	A,B	1KIJ	0.73
NOV	NOVOBIOCIN	A,B	1S14	0.73
NOV	NOVOBIOCIN	A	1AJ6	0.73
AI1	N-BENZYL-3-(ALPHA-D-GALACTOS-1-YL)-BENZAMIDE	D,E,F,G,H,L,M,N,O,P	1FD7	0.73
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	215D	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	235D	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	234D	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A,B	2DES	0.71
SHP	(4-HYDROXYMALTOSEPHENYL)GLYCINE	A	1DSR	0.74
485	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (3,4,5-TRIHYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YL)- ACETIC ACID	A	1JIL	0.71
DM9	N-HYDROXYMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN	A	482D	0.7